9.22.15
The Society For Women’s Health Research Welcomes New Board Member
SWHR is excited to announce the appointment of a new member to its Board of Directors. Joining the Board is Shontelle Dodson, PharmD, vice president of Medical Excellence within Medical Affairs, Global, at Astellas Pharma Inc.
9.17.15 | Policy
SWHR Supports Dr. Robert Califf’s Nomination to Lead FDA
President Barack Obama has nominated distinguished cardiologist and medical researcher Dr. Robert Califf to be the next U.S. Food and Drug Administration (FDA) Commissioner.
8.18.15
SWHR Supports FDA Decision to Approve Female Sexual Dysfunction Treatment
SWHR applauds the Food and Drug Administration (FDA) on the approval of Flibanserin, the first ever medical treatment option for Hypoactive Sexual Desire Disorder (HSDD).
8.17.15
The Society for Women’s Health Research Announces Three New Board Members
SWHR is excited to announce the appointment of three new members to its Board of Directors, Nieca Goldberg, MD, Bruce McEwen, PhD., and David Page, MD.
7.8.15 | Research and Clinical Trials
Congressional Briefing to Explore Biological Sex Differences’ Impact on Medical Research
Women’s health leaders press for female subjects to be included in basic research studies
6.12.15 | Research and Clinical Trials
SWHR Applauds NIH’s New Inclusion Of Sex As A Biological Variable
SWHR supports the National Institute of Health’s (NIH) move to include sex as a biological variable in future research.
6.9.15 | Alzheimer's Disease
SWHR Leads Scientific Roundtable on Alzheimer’s Disease
SWHR held its second interdisciplinary roundtable on understanding sex and gender differences in Alzheimer’s disease May 28-29, 2015 at the Hyatt Regency Crystal City in Arlington, Va.
6.5.15
Flibanserin Nears Approval, But Much Work Remains
The Food and Drug Administration (FDA) Advisory Committee has made history for women by recommending approval of Sprout Pharmaceuticals’ twice-rejected female libido drug Flibanserin.
5.12.15 | Heart Health
SWHR Joins ‘Spread the Word’ Campaign Focusing on Coronary Artery Disease and Women’s Health
SWHR teamed with HealthyWomen, the National Association of Nurse Practitioners in Women’s Health, and the Coalition of Labor Union Women in partnership with CardioDx on a new patient advocacy campaign, Spread the Word, to empower women to be proactive in discussing their heart health.
